Category: health

Changes proposed in the EU body’s regulatory framework aim to create a competitive and sustainable European bioeconomy. The European Commission (EC) has updated its Bioeconomy Strategy,proposing a simplified framework that prioritises a competitive and resilient European economy. For the EU to lead the bio-tech revolution, innovation and investment must be scaled beyond the lab, the read more

Our study provides compelling evidence that investments in effective cancer treatments can yield significant long-term societal benefits N. Meltem Daysal This change enables researchers to assess the effects of radiation therapy without confounding from other treatments. The researchers found that radiation therapy reduced the risk of dying within 10 years of diagnosis by approximately 35%. read more

Our results indicate that there is a need to adapt treatment and follow-up for [patients with diabetes who undergo stent implantation] Thomas Nyström The results show that patients with type 1 diabetes have more than twice the risk of stent complications compared to patients without diabetes. For patients with type 2 diabetes, the risk is read more

The proposed mechanical antibacterial approach offers a new way to use metal-organic frameworks, a Nobel Prize-winning material. An innovative, mechanical technique has shown promise for eliminating biofilms without requiring antibiotics or toxic metals, according to researchers in Sweden. In their study, the team from Chalmers University of Technology coated surfaces with metal-organic frameworks, a nanomaterial read more

The modern Industrial Strategy is informing the UK government’s decisions in the Budget. The UK government’s new Autumn Budget delivers a mixed prospect for life sciences, according to industry experts. While it promises to back AI integration and company scale-ups, with additional commitment to boosting manufacturing capacity, many firms are set to be hit by read more

The variability in what we observe in these patients has long challenged our ability to predict outcomes and tailor their treatment Neil Greening Associate Professor Dr Neil Greening from the University of Leicester’s Department of Respiratory Sciences and Honorary Consultant Respiratory Physician from University Hospitals of Leicester NHS Trust explains: “Exacerbations of COPD remain a read more

Zisis Kozlakidis, Head, Laboratory Services at IARC/WHO reviewed patient-centric digital interaction in public health, highlighting the potential of integrated AI to accelerate discovery, enhance precision medicine and improve public health outcomes. As AUTOMA+ 2025 Technology Partner, Boehringer Ingelheim Pharma GmbH & Co.KG, with Joachim Bär, Director DevOps CellCulture, as speaker, presented a workshop on digital read more

Supply crisis of antibiotics in Europe adds burden to regional efforts to overcome antimicrobial resistance (AMR), says a new report. Procurement reform, policy intervention and international regulatory leadership are all required to address a growing supply chain crisis for system-critical antibiotics in Europe. That’s according to a new report from healthcare consultancy Newmarket Strategy, and read more

R&D projects supported by the Centre for Process Innovation (CPI) aim to shape a sustainable, resilient and competitive future for pharma manufacturing. Innovate UK’s Sustainable Medicines Manufacturing Innovation Programme(SMMIP) is funding eight innovative R&D ‘Grand Challenge’ projects to make medicines manufacturing more efficient, smarter and sustainable. The Programme, part of 2024’sVoluntary Scheme for Branded Medicines read more

Swiss pharma company to trim production of oral medicines and packaging in Stein, while boosting productivity in Schweizerhalle. To maintain competitive production in Switzerland, Novartis is restructuring its workforce, as well as investing in innovative technologies such as automation, according to the firm’s President of Operations, Steffen Lang. The changes involve cutting 550 jobs at read more

Authorisation of the biosimilar Gobivaz provides a substitute biologic medicine to Simponi for individuals with immune-mediated diseases. Alvotech’s Gobivaz biosimilar has been approved in Europe and once launched will offer competition to its originator product, Johnson & Johnson’s monoclonal antibody Simponi (golimumab). The authorisation is for Gobivaz®50 mg/0.5 mL and 100mg/mL in both pre-filled syringe read more

The companies’ partnership covers messenger RNA design and production services. 3D illustration of of a molecular model of messenger ribonucleic acid (mRNA) Biovectra has partnered with US contract development and manufacturing organisation (CDMO) Revolution Biomanufacturing on mRNA design and production. The collaboration combines sequence design expertise with end-to-end GMP manufacturing with the aim of streamlining read more

California site adds to the Swiss pharma company’s operations in Florida and Texas. Credit: Jonathan Weiss / Shutterstock.com Novartis has opened its third manufacturing facility for radioligand therapies, with a new site in Carlsbad, California joining existing locations in Florida and Texas. The move is part of the Swiss pharma company’s $23 billion US expansion read more

The move is part of biopharma’s $50 billion pledge to US medicines manufacturing and R&D. Credit: Roland Magnusson / Shutterstock.com AstraZeneca is channeling $2 billion into its manufacturing capabilities in Maryland, US, representing its fourth major investment in the country so far this year. This commitment is part of the company’s pledge announced in July, read more

Findings presented at the British Thoracic Society (BTS) Winter Meeting back biopharma’s Net Zero commitment. As the UK prepares for regulatory submissions for carbon minimal pMDIs in the coming months, Chiesi has confirmed the therapeutic equivalence of its advanced carbon minimal inhaler (CMI). Two clinical studies compared beclometasone dipropionate/formoterol fumarate product formulated with hydrofluoroalkane (HFA) read more

Novo Nordisk is evaluating oral GLP-1 drug Rybelsus as a potential treatment in early symptomatic Alzheimer’s. Rybelsus (oral semaglutide) did not demonstrate superiority of semaglutide versus placebo in delaying early Alzheimer’s disease progression, according to new phase III topline results from Novo Nordisk. [The topline results] show a fundamental shift in how we approach the read more

Once this bacterium establishes itself, it tends to persist rather than being replaced by new infections. This persistence helps explain why the bug can be so difficult to eradicate in hospital settings Lewis Fisher P. aeruginosa is a common bacterium that can cause disease in humans, plants and animals. It is a major cause of read more

The new single-shot and motion-free method produces images that are more informative, low-dose and faster — helping to lower patients’ dose of radiation, which can be especially beneficial for children and small animals. The cost-effective design could be integrated into existing X-ray and CT systems with only minor modifications, making clinical translation feasible. The team’s read more

European approval of Sanofi and Regeneron’s monoclonal antibody provides eligible urticaria patients with a new first-line targeted treatment option. Following US approval in April of the first new targeted treatment for chronic spontaneous urticaria (CSU) in a decade, the European Commission (EC) has now authorised the same therapy for eligible EU patients. This approval further read more

Phages attacking bacteria under the microscope Image source: University of Southampton Different phages work a bit like different keys – each one can only “unlock” (infect) certain strains of the bacteria. The Klebsiella Phage Collection fully characterises 52 different phages, alongside 74 strains of Klebsiella. These phages come from five viral families, including a newly read more